January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended threshold of 90 minutes after arriving at the hospital, with the median time to...
Structural Heart Occluders
-
-
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) conference in...
-
St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the Amplatzer PFO Occluder to help reduce the risk of recurrent ischemic strokes in...
-
St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional Sizes) pediatric clinical trial. The U.S. IDE clinical trial will evaluate the safety and...
News | Atrial Fibrillation | May 30, 2017
May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC)...
The AtriCure Atriclip surgical LAA occlusion device. It loops over the LAA on the outside of the heart and clips it off from the rest of the heart to prevent the formation of clots.
Feature | Left Atrial Appendage (LAA) Occluders | March 29, 2017
March 29, 2017 — For patients with...
Dr. Dee Dee Wang with part of Henry Ford Hospital's collection of 3-D printed hearts used for education and to preplan structural heart procedures.
Feature | 3-D Printing | March 03, 2017
March 3, 2017 — A Henry Ford Hospital study found a 100 percent success rate in left atrial appendage (LAA)...
News | Structural Heart Occluders | February 15, 2017
February 15, 2017 — Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug...
News | Structural Heart Occluders | February 01, 2017
February 1, 2017 — Baylor Heart and Vascular Services at Fort Worth in November became the first program in Texas to...
News | Cath Lab | January 23, 2017
January 23, 2017 — Over 93 percent of heart attack patients are receiving stents within the guideline-recommended...
Feature | Left Atrial Appendage (LAA) Occluders | November 07, 2016
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high...
News | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First...
Technology | Structural Heart Occluders | November 02, 2016
November 2, 2016 — St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval...
News | Congenital Heart | October 19, 2016
October 19, 2016 — St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II...
News | Left Atrial Appendage (LAA) Occluders | September 02, 2016
September 2, 2016 — St. Jude Medical Inc. announced the start of the St. Jude Medical Amplatzer Amulet IDE trial of...
News | Structural Heart Occluders | August 08, 2016
August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based...
An illustration of a Watchman transcatheter LAA occluder being implanted.
Feature | Left Atrial Appendage (LAA) Occluders | August 01, 2016 | Dave Fornell
Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in...
Videos | Structural Heart Occluders | June 16, 2016
This is an animation, supplied by Gore, demonstrated how the Cardioform Septal Occluder is implanted for the...
Feature | Structural Heart Occluders | May 27, 2016 | Dave Fornell
May 27, 2016 — A U.S. Food and Drug Administration (FDA) panel recommended approval of a transcatheter patent...
